When inflammation causes pain, most people reach for ibuprofen. It’s inexpensive, widely available, and backed by decades of research. But as medical cannabis becomes more widely accepted, many patients wonder whether cannabis could be a safer or even better alternative.
The answer is more nuanced than many headlines suggest.
Current research shows that ibuprofen remains the better-established anti-inflammatory medication, particularly for acute injuries and short-term inflammatory conditions. However, medical cannabis offers unique benefits that may make it an appropriate option for certain patients—especially those living with chronic pain or those who cannot safely take NSAIDs.
How Ibuprofen Reduces Inflammation
Ibuprofen belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking cyclooxygenase (COX-1 and COX-2) enzymes that produce prostaglandins, chemicals that drive pain, swelling, and inflammation.
Because this mechanism is well understood, ibuprofen has been extensively studied in conditions such as:
- Arthritis
- Muscle strains
- Dental pain
- Sports injuries
- Postoperative pain
For these conditions, NSAIDs remain the standard first-line treatment.
How Medical Cannabis Works
Cannabis does not work like ibuprofen.
Instead of blocking prostaglandins, cannabinoids—including THC and CBD—interact with the body’s endocannabinoid system, a network involved in pain perception, immune regulation, inflammation, and nervous system signaling.
Researchers have found that cannabinoids may:
- Reduce inflammatory cytokines such as TNF-α, IL-1β, and IL-6
- Influence immune-cell activity
- Promote resolution of inflammation rather than simply suppressing it
- Affect pain processing within both the brain and spinal cord
These mechanisms are biologically plausible and have shown promise in laboratory and animal studies. However, translating those findings into consistent clinical benefits in humans has proven more challenging.
What Does the Clinical Evidence Show?
This is where it’s important to separate laboratory research from clinical practice.
Current high-quality human studies generally find that NSAIDs outperform cannabinoids for acute inflammatory pain. Head-to-head clinical trials have shown medications such as ibuprofen, naproxen, and ketoprofen provide greater pain relief than the cannabinoid products studied for postoperative and dental pain.
At the same time, researchers continue to investigate cannabinoids because their mechanisms differ from NSAIDs and they may offer advantages in selected chronic conditions or in patients who cannot tolerate traditional anti-inflammatory medications.
Long-Term NSAID Use Is Not Risk-Free
Although ibuprofen is highly effective, it is not appropriate for everyone—especially when used regularly over months or years.
Long-term NSAID use may increase the risk of:
- Stomach ulcers
- Gastrointestinal bleeding
- Kidney injury
- Elevated blood pressure
- Cardiovascular complications in some patients
For individuals at higher risk of these complications, healthcare providers often look for alternative strategies rather than simply increasing NSAID doses.
Where Medical Cannabis May Have a Role
Medical cannabis is not a replacement for ibuprofen in treating acute inflammation. However, it may be considered as part of a comprehensive treatment plan for selected patients with chronic conditions.
Examples include certain patients with:
- Chronic neuropathic pain
- Persistent musculoskeletal pain
- Multiple sclerosis-related symptoms
- Cancer-related symptoms
- Other qualifying conditions under state medical cannabis programs
The goal is often not to eliminate inflammation directly but to improve pain control, sleep, daily function, and quality of life while potentially reducing reliance on medications with significant long-term risks.
Minnesota and Iowa Medical Cannabis Programs
Patients living in Minnesota or Iowa may qualify for medical cannabis if they have certain qualifying medical conditions established by state law.
At DPC Medical–Dodson Pain Consultants, we evaluate patients individually to determine whether medical cannabis may be an appropriate component of a personalized treatment plan. Decisions are based on medical history, current medications, potential benefits, and possible risks.
Please contact us for further information.
Bottom Line
Current evidence supports ibuprofen as the better-established anti-inflammatory medication for acute inflammatory conditions. However, that does not mean medical cannabis lacks value.
For some patients—particularly those living with chronic pain or those who cannot safely use NSAIDs—medical cannabis may provide meaningful symptom relief as part of an individualized treatment plan. The most appropriate treatment depends on the condition being treated, the patient’s overall health, and a careful discussion with a qualified healthcare provider.
For more information Please read one of our previous articles: Medical Cannabis in Minnesota: Understanding the 3-year Card Advantage and/or Do I qualify for Medical Cannabis in Minnesota? (2026 Guide)